Related Experiment Video
Updated: Feb 8, 2026

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
Published on: January 7, 2019
Sirtuin-4 (SIRT4), a therapeutic target with oncogenic and tumor-suppressive activity in cancer
1Department of Gastrointestinal Surgery, The First Affiliated Hospital, Wenzhou Medical University, Wenzhou, People's Republic of China.
Abstract:
Several members of the sirtuin (SIRT) family, a highly conserved family of NAD+-dependent enzymes, have been shown to play a critical role in both promoting and/or suppressing tumorigenesis. In this study, recent progress in the field concerning SIRT4 and cancer was reviewed, and the relationship between SIRT4 and tumors was investigated. Subsequently, we evaluated the role of SIRT4 with oncogenic or tumor-suppressive activity in cancer, which may provide insight in identifying the underlying mechanism of action of SIRT4 in cancer. Finally, we explored the potential of SIRT4 as a therapeutic target in cancer therapy.
Insights
Sirtuin 4 (SIRT4) plays a complex role in cancer, acting as both an oncogene and tumor suppressor. This review explores SIRT4
Area of Science:
- Biochemistry and Molecular Biology
- Oncology
- Genetics
Background:
- Sirtuins (SIRTs) are NAD+-dependent enzymes involved in cellular regulation.
- Members of the SIRT family exhibit diverse roles in tumorigenesis, either promoting or suppressing tumor development.
- SIRT4's specific function in cancer remains incompletely understood.
Purpose of the Study:
- To review recent advancements regarding SIRT4 in the context of cancer.
- To investigate the multifaceted relationship between SIRT4 and various tumor types.
- To evaluate SIRT4's potential as a therapeutic target for cancer treatment.
Main Methods:
- Literature review of recent studies on SIRT4 and cancer.
- Analysis of SIRT4's dual role as an oncogene and tumor suppressor.
- Exploration of SIRT4's mechanistic pathways in tumorigenesis.
Main Results:
- SIRT4 exhibits context-dependent functions in cancer, acting as both an oncogene and a tumor suppressor.
- Evidence suggests SIRT4 influences key cellular processes relevant to cancer progression.
- Understanding SIRT4's mechanism is crucial for its therapeutic application.
Conclusions:
- SIRT4's complex role in cancer necessitates further investigation.
- SIRT4 presents a potential, albeit complex, therapeutic target in oncology.
- Targeting SIRT4 may offer novel strategies for cancer therapy.
Related Concept Videos
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Therapeutic Index
Techniques of therapeutic communication I: Active Listening, Sharing Observations, Validation, and Using Touch
Therapeutic communication is not the same as social interaction. Social interaction has no goal or purpose and consists of casual information sharing, whereas therapeutic communication has a plan or purpose for the conversation. Therapeutic...

